Please welcome our newest faculty members joining the Mays Cancer Center in the Division of Hematology and Oncology.
Heidi Ko, MD, joins our breast oncology team as an assistant professor focusing on breast medical oncology. Dr. Ko received her medical degree from Rowan University School of Osteopathic Medicine in Stratford, New Jersey. She completed her residency in internal medicine at McGovern Medical School at The University of Texas Health Science Center at Houston. […]
UT Health San Antonio cardio-oncology program recognized as a Center of Excellence
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – The cardio-oncology program at The University of Texas Health Science Center at San Antonio has been recognized by the International Cardio-Oncology Society as a Center of Excellence, reflecting its exceptionally high level of expertise in cardiovascular care of cancer patients and survivors. Cardio-oncology is a quickly developing […]
One in three Latinos will face cancer in their lifetime: Conference to address disparities, health inequities
Advancing the Science of Cancer in Latinos event set for Feb. 23-25 Media contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu On-site contact: Cliff Despres, (210) 562-6517, despres@uthscsa.edu Written by Cliff Despres, Institute for Health Promotion Research, UT Health San Antonio SAN ANTONIO — With one in three Latinos facing a cancer diagnosis in their lifetime, UT […]
Carissia Calvo–Strube, M.D. Surgical Oncology, Breast Surgical Oncology
First lady Jill Biden visits Mays Cancer Center
First lady Jill Biden toured Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Latinos.
First lady Jill Biden visits Mays Cancer Center, lauds its cancer research and its role in addressing Latino cancer health disparities
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – First lady Jill Biden toured Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), and praised its efforts in addressing disparities in cancer rates among Latinos. The visit came on the same day as the opening of the […]
Mays Cancer Center studies help spur leukemia drug’s approval
The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]